RVMD compared with AMGN: revenue, margins and what each company keeps, and the suppliers and customers both name

RVMDRevolution Medicines, Inc.

Mkt capRevenueRevenue

AMGNAmgen Inc

Mkt capRevenueRevenue

Compare

RVMDRevolution Medicines, Inc.

AMGNAmgen Inc

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

RVMD: latest quarter is a loss; flow not drawable.Method ›

RVMDRevolution Medicines, Inc.

186.60▼−6.56%

Mkt cap$43.2BRevenue$198MQ3 FY26Revenue—

AMGNAmgen Inc

468.98▼−1.99%

Regular sessionNov 5 '26

Mkt cap$258.8BRevenue$10.4BQ3 FY26Revenue$36.8BFY25

Compare

Regular sessionNov 5 '26

RVMDRevolution Medicines, Inc.

AMGNAmgen Inc

186.60▼−6.56%

Price

468.98▼−1.99%

$43.2B

Mkt cap

$258.8B

Q3 FY26$198M

Revenue

$10.4BQ3 FY26

—

Revenue

$36.8BFY25

RVMD186.60▼−6.56%vsAMGN468.98▼−1.99%Regular sessionNov 5 '26

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only RVMD 6

SNYSanoficustomer

RPRXRoyalty Pharma Investments 2019 ICAV (Royalty Pharma)customer

—Aethon Therapeuticsunlistedsupplier

—Continental Stock Transfer & Trustunlistedsupplier

2 more · RVMD chain ›

Shared 0

No shared counterparties.

Only AMGN 12

PODDInsuletsupplier

CYTKCytokineticssupplier

ARWRArrowhead Pharmaceuticalssupplier

LGNDLigand Pharmaceuticalssupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

8 more · AMGN chain ›

Price

rebased to 0%

RVMD, solidAMGN, dashed